Literature DB >> 16148109

Induction of regulatory properties in dendritic cells by Valpha14 NKT cells.

Satoshi Kojo1, Ken-Ichiro Seino, Michishige Harada, Hiroshi Watarai, Hiroshi Wakao, Tetsuro Uchida, Toshinori Nakayama, Masaru Taniguchi.   

Abstract

Valpha14 NKT cells exhibit various immune regulatory properties in vivo, but their precise mechanisms remain to be solved. In this study, we demonstrate the mechanisms of generation of regulatory dendritic cells (DCs) by stimulation of Valpha14 NKT cells in vivo. After repeated injection of alpha-galactosylceramide (alpha-GalCer) into mice, splenic DCs acquired properties of regulatory DCs in IL-10-dependent fashion, such as nonmatured phenotypes and increased IL-10 but reduced IL-12 production. The unique cytokine profile in these DCs appears to be regulated by ERK1/2 and IkappaB(NS). These DCs also showed an ability to suppress the development of experimental allergic encephalomyelitis by generating IL-10-producing regulatory CD4 T cells in vivo. These findings contribute to explaining how Valpha14 NKT cells regulate the immune responses in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148109     DOI: 10.4049/jimmunol.175.6.3648

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.

Authors:  Sayuri Yamazaki; Munjal Patel; Alice Harper; Anthony Bonito; Hidehiro Fukuyama; Maggi Pack; Kristin V Tarbell; Mia Talmor; Jeffrey V Ravetch; Kayo Inaba; Ralph M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

2.  Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure.

Authors:  Melanie J Ragin; Nisebita Sahu; Avery August
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset.

Authors:  Duygu Sag; Petra Krause; Catherine C Hedrick; Mitchell Kronenberg; Gerhard Wingender
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

Review 4.  Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Authors:  Luc Van Kaer; Lan Wu; Vrajesh V Parekh
Journal:  Immunology       Date:  2015-06-22       Impact factor: 7.397

5.  Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.

Authors:  Vrajesh V Parekh; Lan Wu; Danyvid Olivares-Villagómez; Keith T Wilson; Luc Van Kaer
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

6.  Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.

Authors:  Aurore Miellot-Gafsou; Jérôme Biton; Elvire Bourgeois; André Herbelin; Marie-Christophe Boissier; Natacha Bessis
Journal:  Immunology       Date:  2010-01-27       Impact factor: 7.397

7.  Targeting myeloid regulatory cells in cancer by chemotherapeutic agents.

Authors:  Hiam Naiditch; Michael R Shurin; Galina V Shurin
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

8.  Chronic alcohol consumption enhances iNKT cell maturation and activation.

Authors:  Hui Zhang; Faya Zhang; Zhaohui Zhu; Dung Luong; Gary G Meadows
Journal:  Toxicol Appl Pharmacol       Date:  2014-12-09       Impact factor: 4.219

9.  The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells.

Authors:  Chi-Keung Wan; Jangsuk Oh; Peng Li; Erin E West; Elizabeth A Wong; Allison B Andraski; Rosanne Spolski; Zu-Xi Yu; Jianping He; Brian L Kelsall; Warren J Leonard
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

10.  Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette.

Authors:  John P Driver; Felix Scheuplein; Yi-Guang Chen; Alexandra E Grier; S Brian Wilson; David V Serreze
Journal:  Diabetes       Date:  2009-11-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.